nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—EDNRB—melanoma	0.732	1	CbGaD
Bosentan—CYP3A4—Temozolomide—melanoma	0.0279	0.576	CbGbCtD
Bosentan—CYP3A4—Vemurafenib—melanoma	0.0153	0.316	CbGbCtD
Bosentan—CYP3A4—Docetaxel—melanoma	0.00525	0.108	CbGbCtD
Bosentan—Asthenia—Vemurafenib—melanoma	0.000272	0.0022	CcSEcCtD
Bosentan—Hypoaesthesia—Temozolomide—melanoma	0.000272	0.00219	CcSEcCtD
Bosentan—Chills—Dactinomycin—melanoma	0.000271	0.00219	CcSEcCtD
Bosentan—Urinary tract disorder—Temozolomide—melanoma	0.00027	0.00218	CcSEcCtD
Bosentan—Oedema peripheral—Temozolomide—melanoma	0.000269	0.00217	CcSEcCtD
Bosentan—Cardiac failure—Docetaxel—melanoma	0.000269	0.00217	CcSEcCtD
Bosentan—Pruritus—Vemurafenib—melanoma	0.000268	0.00217	CcSEcCtD
Bosentan—Lethargy—Docetaxel—melanoma	0.000268	0.00216	CcSEcCtD
Bosentan—Urethral disorder—Temozolomide—melanoma	0.000268	0.00216	CcSEcCtD
Bosentan—Eye disorder—Carmustine—melanoma	0.000264	0.00213	CcSEcCtD
Bosentan—Hyponatraemia—Docetaxel—melanoma	0.000263	0.00213	CcSEcCtD
Bosentan—Erythema—Dactinomycin—melanoma	0.000263	0.00212	CcSEcCtD
Bosentan—Pain in extremity—Docetaxel—melanoma	0.000262	0.00212	CcSEcCtD
Bosentan—Flushing—Carmustine—melanoma	0.000262	0.00212	CcSEcCtD
Bosentan—Anaemia—Bleomycin—melanoma	0.00026	0.0021	CcSEcCtD
Bosentan—Diarrhoea—Vemurafenib—melanoma	0.00026	0.0021	CcSEcCtD
Bosentan—Erythema multiforme—Temozolomide—melanoma	0.000258	0.00209	CcSEcCtD
Bosentan—Eye disorder—Temozolomide—melanoma	0.000255	0.00206	CcSEcCtD
Bosentan—Tinnitus—Temozolomide—melanoma	0.000255	0.00206	CcSEcCtD
Bosentan—Flushing—Temozolomide—melanoma	0.000253	0.00205	CcSEcCtD
Bosentan—Cardiac disorder—Temozolomide—melanoma	0.000253	0.00205	CcSEcCtD
Bosentan—Leukopenia—Bleomycin—melanoma	0.000252	0.00204	CcSEcCtD
Bosentan—Dizziness—Vemurafenib—melanoma	0.000251	0.00203	CcSEcCtD
Bosentan—Angiopathy—Temozolomide—melanoma	0.000248	0.002	CcSEcCtD
Bosentan—Mental disorder—Carmustine—melanoma	0.000247	0.002	CcSEcCtD
Bosentan—Immune system disorder—Temozolomide—melanoma	0.000247	0.00199	CcSEcCtD
Bosentan—Mediastinal disorder—Temozolomide—melanoma	0.000246	0.00199	CcSEcCtD
Bosentan—Malnutrition—Carmustine—melanoma	0.000246	0.00199	CcSEcCtD
Bosentan—Erythema—Carmustine—melanoma	0.000246	0.00199	CcSEcCtD
Bosentan—Cough—Bleomycin—melanoma	0.000246	0.00199	CcSEcCtD
Bosentan—Chills—Temozolomide—melanoma	0.000245	0.00198	CcSEcCtD
Bosentan—Dehydration—Docetaxel—melanoma	0.000244	0.00197	CcSEcCtD
Bosentan—Anaemia—Dactinomycin—melanoma	0.000243	0.00196	CcSEcCtD
Bosentan—Liver function test abnormal—Docetaxel—melanoma	0.000242	0.00196	CcSEcCtD
Bosentan—Vomiting—Vemurafenib—melanoma	0.000241	0.00195	CcSEcCtD
Bosentan—Dry skin—Docetaxel—melanoma	0.000241	0.00194	CcSEcCtD
Bosentan—Chest pain—Bleomycin—melanoma	0.00024	0.00194	CcSEcCtD
Bosentan—Orthostatic hypotension—Docetaxel—melanoma	0.00024	0.00194	CcSEcCtD
Bosentan—Abdominal pain upper—Docetaxel—melanoma	0.00024	0.00194	CcSEcCtD
Bosentan—Rash—Vemurafenib—melanoma	0.000239	0.00193	CcSEcCtD
Bosentan—Mental disorder—Temozolomide—melanoma	0.000239	0.00193	CcSEcCtD
Bosentan—Dermatitis—Vemurafenib—melanoma	0.000239	0.00193	CcSEcCtD
Bosentan—Back pain—Carmustine—melanoma	0.000238	0.00192	CcSEcCtD
Bosentan—Headache—Vemurafenib—melanoma	0.000238	0.00192	CcSEcCtD
Bosentan—Erythema—Temozolomide—melanoma	0.000238	0.00192	CcSEcCtD
Bosentan—Malnutrition—Temozolomide—melanoma	0.000238	0.00192	CcSEcCtD
Bosentan—Discomfort—Bleomycin—melanoma	0.000237	0.00191	CcSEcCtD
Bosentan—Cramp muscle—Docetaxel—melanoma	0.000236	0.00191	CcSEcCtD
Bosentan—Leukopenia—Dactinomycin—melanoma	0.000235	0.0019	CcSEcCtD
Bosentan—Nasopharyngitis—Docetaxel—melanoma	0.000235	0.0019	CcSEcCtD
Bosentan—Vision blurred—Carmustine—melanoma	0.000232	0.00187	CcSEcCtD
Bosentan—Tremor—Carmustine—melanoma	0.00023	0.00186	CcSEcCtD
Bosentan—Oedema—Bleomycin—melanoma	0.00023	0.00186	CcSEcCtD
Bosentan—Anaphylactic shock—Bleomycin—melanoma	0.00023	0.00186	CcSEcCtD
Bosentan—Back pain—Temozolomide—melanoma	0.00023	0.00186	CcSEcCtD
Bosentan—Infection—Bleomycin—melanoma	0.000228	0.00185	CcSEcCtD
Bosentan—Anaemia—Carmustine—melanoma	0.000227	0.00184	CcSEcCtD
Bosentan—Nausea—Vemurafenib—melanoma	0.000225	0.00182	CcSEcCtD
Bosentan—Thrombocytopenia—Bleomycin—melanoma	0.000225	0.00182	CcSEcCtD
Bosentan—Vision blurred—Temozolomide—melanoma	0.000224	0.00181	CcSEcCtD
Bosentan—Bronchospasm—Docetaxel—melanoma	0.000223	0.0018	CcSEcCtD
Bosentan—Tremor—Temozolomide—melanoma	0.000223	0.0018	CcSEcCtD
Bosentan—Discomfort—Dactinomycin—melanoma	0.000221	0.00179	CcSEcCtD
Bosentan—Angina pectoris—Docetaxel—melanoma	0.000221	0.00179	CcSEcCtD
Bosentan—Leukopenia—Carmustine—melanoma	0.00022	0.00178	CcSEcCtD
Bosentan—Anaemia—Temozolomide—melanoma	0.00022	0.00177	CcSEcCtD
Bosentan—Anorexia—Bleomycin—melanoma	0.000219	0.00177	CcSEcCtD
Bosentan—Angioedema—Temozolomide—melanoma	0.000217	0.00175	CcSEcCtD
Bosentan—Hypotension—Bleomycin—melanoma	0.000215	0.00174	CcSEcCtD
Bosentan—Oedema—Dactinomycin—melanoma	0.000214	0.00173	CcSEcCtD
Bosentan—Vertigo—Temozolomide—melanoma	0.000213	0.00173	CcSEcCtD
Bosentan—Infection—Dactinomycin—melanoma	0.000213	0.00172	CcSEcCtD
Bosentan—Leukopenia—Temozolomide—melanoma	0.000213	0.00172	CcSEcCtD
Bosentan—Neutropenia—Docetaxel—melanoma	0.000212	0.00171	CcSEcCtD
Bosentan—Palpitations—Temozolomide—melanoma	0.00021	0.0017	CcSEcCtD
Bosentan—Thrombocytopenia—Dactinomycin—melanoma	0.00021	0.0017	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Bleomycin—melanoma	0.000209	0.00169	CcSEcCtD
Bosentan—Chest pain—Carmustine—melanoma	0.000209	0.00169	CcSEcCtD
Bosentan—Anxiety—Carmustine—melanoma	0.000209	0.00169	CcSEcCtD
Bosentan—Cough—Temozolomide—melanoma	0.000207	0.00168	CcSEcCtD
Bosentan—Paraesthesia—Bleomycin—melanoma	0.000206	0.00167	CcSEcCtD
Bosentan—Weight increased—Docetaxel—melanoma	0.000206	0.00167	CcSEcCtD
Bosentan—Weight decreased—Docetaxel—melanoma	0.000205	0.00166	CcSEcCtD
Bosentan—Dyspnoea—Bleomycin—melanoma	0.000205	0.00166	CcSEcCtD
Bosentan—Anorexia—Dactinomycin—melanoma	0.000204	0.00165	CcSEcCtD
Bosentan—Pneumonia—Docetaxel—melanoma	0.000203	0.00164	CcSEcCtD
Bosentan—Arthralgia—Temozolomide—melanoma	0.000202	0.00163	CcSEcCtD
Bosentan—Infestation—Docetaxel—melanoma	0.000202	0.00163	CcSEcCtD
Bosentan—Infestation NOS—Docetaxel—melanoma	0.000202	0.00163	CcSEcCtD
Bosentan—Anxiety—Temozolomide—melanoma	0.000202	0.00163	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000201	0.00162	CcSEcCtD
Bosentan—Oedema—Carmustine—melanoma	0.000201	0.00162	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Docetaxel—melanoma	0.0002	0.00162	CcSEcCtD
Bosentan—Discomfort—Temozolomide—melanoma	0.0002	0.00162	CcSEcCtD
Bosentan—Decreased appetite—Bleomycin—melanoma	0.0002	0.00161	CcSEcCtD
Bosentan—Infection—Carmustine—melanoma	0.000199	0.00161	CcSEcCtD
Bosentan—Acute coronary syndrome—Docetaxel—melanoma	0.000199	0.00161	CcSEcCtD
Bosentan—Renal failure—Docetaxel—melanoma	0.000199	0.00161	CcSEcCtD
Bosentan—Myocardial infarction—Docetaxel—melanoma	0.000198	0.0016	CcSEcCtD
Bosentan—Dry mouth—Temozolomide—melanoma	0.000198	0.0016	CcSEcCtD
Bosentan—Jaundice—Docetaxel—melanoma	0.000197	0.00159	CcSEcCtD
Bosentan—Stomatitis—Docetaxel—melanoma	0.000197	0.00159	CcSEcCtD
Bosentan—Pain—Bleomycin—melanoma	0.000197	0.00159	CcSEcCtD
Bosentan—Conjunctivitis—Docetaxel—melanoma	0.000197	0.00159	CcSEcCtD
Bosentan—Thrombocytopenia—Carmustine—melanoma	0.000196	0.00159	CcSEcCtD
Bosentan—Tachycardia—Carmustine—melanoma	0.000196	0.00158	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000195	0.00158	CcSEcCtD
Bosentan—Oedema—Temozolomide—melanoma	0.000194	0.00157	CcSEcCtD
Bosentan—Anaphylactic shock—Temozolomide—melanoma	0.000194	0.00157	CcSEcCtD
Bosentan—Infection—Temozolomide—melanoma	0.000193	0.00156	CcSEcCtD
Bosentan—Anorexia—Carmustine—melanoma	0.000191	0.00155	CcSEcCtD
Bosentan—Hepatobiliary disease—Docetaxel—melanoma	0.000191	0.00155	CcSEcCtD
Bosentan—Epistaxis—Docetaxel—melanoma	0.000191	0.00154	CcSEcCtD
Bosentan—Nervous system disorder—Temozolomide—melanoma	0.00019	0.00154	CcSEcCtD
Bosentan—Thrombocytopenia—Temozolomide—melanoma	0.00019	0.00153	CcSEcCtD
Bosentan—Skin disorder—Temozolomide—melanoma	0.000188	0.00152	CcSEcCtD
Bosentan—Hypotension—Carmustine—melanoma	0.000188	0.00152	CcSEcCtD
Bosentan—Hyperhidrosis—Temozolomide—melanoma	0.000187	0.00151	CcSEcCtD
Bosentan—Decreased appetite—Dactinomycin—melanoma	0.000186	0.00151	CcSEcCtD
Bosentan—Fatigue—Dactinomycin—melanoma	0.000185	0.00149	CcSEcCtD
Bosentan—Anorexia—Temozolomide—melanoma	0.000185	0.00149	CcSEcCtD
Bosentan—Pain—Dactinomycin—melanoma	0.000183	0.00148	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Carmustine—melanoma	0.000183	0.00148	CcSEcCtD
Bosentan—Urticaria—Bleomycin—melanoma	0.000183	0.00148	CcSEcCtD
Bosentan—Haemoglobin—Docetaxel—melanoma	0.000182	0.00147	CcSEcCtD
Bosentan—Body temperature increased—Bleomycin—melanoma	0.000182	0.00147	CcSEcCtD
Bosentan—Haemorrhage—Docetaxel—melanoma	0.000182	0.00147	CcSEcCtD
Bosentan—Hepatitis—Docetaxel—melanoma	0.000182	0.00147	CcSEcCtD
Bosentan—Insomnia—Carmustine—melanoma	0.000182	0.00147	CcSEcCtD
Bosentan—Hypoaesthesia—Docetaxel—melanoma	0.000181	0.00146	CcSEcCtD
Bosentan—Paraesthesia—Carmustine—melanoma	0.00018	0.00146	CcSEcCtD
Bosentan—Urinary tract disorder—Docetaxel—melanoma	0.000179	0.00145	CcSEcCtD
Bosentan—Dyspnoea—Carmustine—melanoma	0.000179	0.00145	CcSEcCtD
Bosentan—Oedema peripheral—Docetaxel—melanoma	0.000179	0.00144	CcSEcCtD
Bosentan—Somnolence—Carmustine—melanoma	0.000178	0.00144	CcSEcCtD
Bosentan—Urethral disorder—Docetaxel—melanoma	0.000178	0.00144	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Temozolomide—melanoma	0.000177	0.00143	CcSEcCtD
Bosentan—Insomnia—Temozolomide—melanoma	0.000175	0.00142	CcSEcCtD
Bosentan—Gastrointestinal pain—Dactinomycin—melanoma	0.000175	0.00142	CcSEcCtD
Bosentan—Decreased appetite—Carmustine—melanoma	0.000174	0.00141	CcSEcCtD
Bosentan—Paraesthesia—Temozolomide—melanoma	0.000174	0.00141	CcSEcCtD
Bosentan—Gastrointestinal disorder—Carmustine—melanoma	0.000173	0.0014	CcSEcCtD
Bosentan—Dyspnoea—Temozolomide—melanoma	0.000173	0.0014	CcSEcCtD
Bosentan—Somnolence—Temozolomide—melanoma	0.000172	0.00139	CcSEcCtD
Bosentan—Erythema multiforme—Docetaxel—melanoma	0.000172	0.00139	CcSEcCtD
Bosentan—Pain—Carmustine—melanoma	0.000172	0.00139	CcSEcCtD
Bosentan—Constipation—Carmustine—melanoma	0.000172	0.00139	CcSEcCtD
Bosentan—Dyspepsia—Temozolomide—melanoma	0.000171	0.00138	CcSEcCtD
Bosentan—Eye disorder—Docetaxel—melanoma	0.00017	0.00137	CcSEcCtD
Bosentan—Body temperature increased—Dactinomycin—melanoma	0.000169	0.00137	CcSEcCtD
Bosentan—Abdominal pain—Dactinomycin—melanoma	0.000169	0.00137	CcSEcCtD
Bosentan—Hypersensitivity—Bleomycin—melanoma	0.000169	0.00137	CcSEcCtD
Bosentan—Decreased appetite—Temozolomide—melanoma	0.000169	0.00136	CcSEcCtD
Bosentan—Flushing—Docetaxel—melanoma	0.000168	0.00136	CcSEcCtD
Bosentan—Cardiac disorder—Docetaxel—melanoma	0.000168	0.00136	CcSEcCtD
Bosentan—Gastrointestinal disorder—Temozolomide—melanoma	0.000167	0.00135	CcSEcCtD
Bosentan—Fatigue—Temozolomide—melanoma	0.000167	0.00135	CcSEcCtD
Bosentan—Constipation—Temozolomide—melanoma	0.000166	0.00134	CcSEcCtD
Bosentan—Pain—Temozolomide—melanoma	0.000166	0.00134	CcSEcCtD
Bosentan—Asthenia—Bleomycin—melanoma	0.000165	0.00133	CcSEcCtD
Bosentan—Angiopathy—Docetaxel—melanoma	0.000165	0.00133	CcSEcCtD
Bosentan—Gastrointestinal pain—Carmustine—melanoma	0.000164	0.00133	CcSEcCtD
Bosentan—Immune system disorder—Docetaxel—melanoma	0.000164	0.00132	CcSEcCtD
Bosentan—Mediastinal disorder—Docetaxel—melanoma	0.000164	0.00132	CcSEcCtD
Bosentan—Chills—Docetaxel—melanoma	0.000163	0.00132	CcSEcCtD
Bosentan—Pruritus—Bleomycin—melanoma	0.000163	0.00131	CcSEcCtD
Bosentan—Mental disorder—Docetaxel—melanoma	0.000159	0.00129	CcSEcCtD
Bosentan—Body temperature increased—Carmustine—melanoma	0.000159	0.00128	CcSEcCtD
Bosentan—Abdominal pain—Carmustine—melanoma	0.000159	0.00128	CcSEcCtD
Bosentan—Gastrointestinal pain—Temozolomide—melanoma	0.000159	0.00128	CcSEcCtD
Bosentan—Malnutrition—Docetaxel—melanoma	0.000158	0.00128	CcSEcCtD
Bosentan—Erythema—Docetaxel—melanoma	0.000158	0.00128	CcSEcCtD
Bosentan—Hypersensitivity—Dactinomycin—melanoma	0.000158	0.00128	CcSEcCtD
Bosentan—Urticaria—Temozolomide—melanoma	0.000154	0.00124	CcSEcCtD
Bosentan—Asthenia—Dactinomycin—melanoma	0.000154	0.00124	CcSEcCtD
Bosentan—Abdominal pain—Temozolomide—melanoma	0.000153	0.00124	CcSEcCtD
Bosentan—Body temperature increased—Temozolomide—melanoma	0.000153	0.00124	CcSEcCtD
Bosentan—Back pain—Docetaxel—melanoma	0.000153	0.00124	CcSEcCtD
Bosentan—Muscle spasms—Docetaxel—melanoma	0.000152	0.00123	CcSEcCtD
Bosentan—Hypersensitivity—Carmustine—melanoma	0.000148	0.00119	CcSEcCtD
Bosentan—Diarrhoea—Dactinomycin—melanoma	0.000147	0.00119	CcSEcCtD
Bosentan—Vomiting—Bleomycin—melanoma	0.000146	0.00118	CcSEcCtD
Bosentan—Anaemia—Docetaxel—melanoma	0.000146	0.00118	CcSEcCtD
Bosentan—Rash—Bleomycin—melanoma	0.000145	0.00117	CcSEcCtD
Bosentan—Dermatitis—Bleomycin—melanoma	0.000145	0.00117	CcSEcCtD
Bosentan—Asthenia—Carmustine—melanoma	0.000144	0.00116	CcSEcCtD
Bosentan—Hypersensitivity—Temozolomide—melanoma	0.000143	0.00115	CcSEcCtD
Bosentan—Syncope—Docetaxel—melanoma	0.000142	0.00115	CcSEcCtD
Bosentan—Leukopenia—Docetaxel—melanoma	0.000141	0.00114	CcSEcCtD
Bosentan—Palpitations—Docetaxel—melanoma	0.00014	0.00113	CcSEcCtD
Bosentan—Asthenia—Temozolomide—melanoma	0.000139	0.00112	CcSEcCtD
Bosentan—Loss of consciousness—Docetaxel—melanoma	0.000139	0.00112	CcSEcCtD
Bosentan—Cough—Docetaxel—melanoma	0.000138	0.00111	CcSEcCtD
Bosentan—Diarrhoea—Carmustine—melanoma	0.000137	0.00111	CcSEcCtD
Bosentan—Pruritus—Temozolomide—melanoma	0.000137	0.00111	CcSEcCtD
Bosentan—Nausea—Bleomycin—melanoma	0.000137	0.0011	CcSEcCtD
Bosentan—Vomiting—Dactinomycin—melanoma	0.000136	0.0011	CcSEcCtD
Bosentan—Rash—Dactinomycin—melanoma	0.000135	0.00109	CcSEcCtD
Bosentan—Arthralgia—Docetaxel—melanoma	0.000135	0.00109	CcSEcCtD
Bosentan—Chest pain—Docetaxel—melanoma	0.000135	0.00109	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000134	0.00108	CcSEcCtD
Bosentan—Dizziness—Carmustine—melanoma	0.000133	0.00107	CcSEcCtD
Bosentan—Diarrhoea—Temozolomide—melanoma	0.000133	0.00107	CcSEcCtD
Bosentan—Dry mouth—Docetaxel—melanoma	0.000132	0.00106	CcSEcCtD
Bosentan—Anaphylactic shock—Docetaxel—melanoma	0.000129	0.00104	CcSEcCtD
Bosentan—Oedema—Docetaxel—melanoma	0.000129	0.00104	CcSEcCtD
Bosentan—Dizziness—Temozolomide—melanoma	0.000128	0.00104	CcSEcCtD
Bosentan—Infection—Docetaxel—melanoma	0.000128	0.00104	CcSEcCtD
Bosentan—Vomiting—Carmustine—melanoma	0.000128	0.00103	CcSEcCtD
Bosentan—Nausea—Dactinomycin—melanoma	0.000127	0.00103	CcSEcCtD
Bosentan—Shock—Docetaxel—melanoma	0.000127	0.00103	CcSEcCtD
Bosentan—Rash—Carmustine—melanoma	0.000127	0.00102	CcSEcCtD
Bosentan—Nervous system disorder—Docetaxel—melanoma	0.000126	0.00102	CcSEcCtD
Bosentan—Dermatitis—Carmustine—melanoma	0.000126	0.00102	CcSEcCtD
Bosentan—Thrombocytopenia—Docetaxel—melanoma	0.000126	0.00102	CcSEcCtD
Bosentan—Tachycardia—Docetaxel—melanoma	0.000126	0.00102	CcSEcCtD
Bosentan—Headache—Carmustine—melanoma	0.000126	0.00102	CcSEcCtD
Bosentan—Skin disorder—Docetaxel—melanoma	0.000125	0.00101	CcSEcCtD
Bosentan—Vomiting—Temozolomide—melanoma	0.000123	0.000996	CcSEcCtD
Bosentan—Anorexia—Docetaxel—melanoma	0.000123	0.000993	CcSEcCtD
Bosentan—Rash—Temozolomide—melanoma	0.000122	0.000988	CcSEcCtD
Bosentan—Dermatitis—Temozolomide—melanoma	0.000122	0.000987	CcSEcCtD
Bosentan—Headache—Temozolomide—melanoma	0.000121	0.000982	CcSEcCtD
Bosentan—Hypotension—Docetaxel—melanoma	0.000121	0.000974	CcSEcCtD
Bosentan—Nausea—Carmustine—melanoma	0.000119	0.000963	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Docetaxel—melanoma	0.000117	0.000949	CcSEcCtD
Bosentan—Insomnia—Docetaxel—melanoma	0.000117	0.000943	CcSEcCtD
Bosentan—Paraesthesia—Docetaxel—melanoma	0.000116	0.000936	CcSEcCtD
Bosentan—Nausea—Temozolomide—melanoma	0.000115	0.000931	CcSEcCtD
Bosentan—Dyspnoea—Docetaxel—melanoma	0.000115	0.000929	CcSEcCtD
Bosentan—Somnolence—Docetaxel—melanoma	0.000115	0.000926	CcSEcCtD
Bosentan—Dyspepsia—Docetaxel—melanoma	0.000114	0.000917	CcSEcCtD
Bosentan—Decreased appetite—Docetaxel—melanoma	0.000112	0.000906	CcSEcCtD
Bosentan—Gastrointestinal disorder—Docetaxel—melanoma	0.000111	0.0009	CcSEcCtD
Bosentan—Fatigue—Docetaxel—melanoma	0.000111	0.000898	CcSEcCtD
Bosentan—Pain—Docetaxel—melanoma	0.00011	0.000891	CcSEcCtD
Bosentan—Constipation—Docetaxel—melanoma	0.00011	0.000891	CcSEcCtD
Bosentan—Gastrointestinal pain—Docetaxel—melanoma	0.000105	0.000852	CcSEcCtD
Bosentan—Abdominal pain—Docetaxel—melanoma	0.000102	0.000824	CcSEcCtD
Bosentan—Body temperature increased—Docetaxel—melanoma	0.000102	0.000824	CcSEcCtD
Bosentan—Hypersensitivity—Docetaxel—melanoma	9.5e-05	0.000768	CcSEcCtD
Bosentan—Asthenia—Docetaxel—melanoma	9.25e-05	0.000748	CcSEcCtD
Bosentan—Pruritus—Docetaxel—melanoma	9.12e-05	0.000737	CcSEcCtD
Bosentan—Diarrhoea—Docetaxel—melanoma	8.82e-05	0.000713	CcSEcCtD
Bosentan—Dizziness—Docetaxel—melanoma	8.53e-05	0.000689	CcSEcCtD
Bosentan—Vomiting—Docetaxel—melanoma	8.2e-05	0.000663	CcSEcCtD
Bosentan—Rash—Docetaxel—melanoma	8.13e-05	0.000657	CcSEcCtD
Bosentan—Dermatitis—Docetaxel—melanoma	8.12e-05	0.000656	CcSEcCtD
Bosentan—Headache—Docetaxel—melanoma	8.08e-05	0.000653	CcSEcCtD
Bosentan—Nausea—Docetaxel—melanoma	7.66e-05	0.000619	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—MAP2K2—melanoma	2.95e-05	0.000306	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL8—melanoma	2.94e-05	0.000306	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.92e-05	0.000304	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CG—melanoma	2.86e-05	0.000297	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ACER3—melanoma	2.85e-05	0.000297	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP1B1—melanoma	2.82e-05	0.000294	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.82e-05	0.000293	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL2—melanoma	2.81e-05	0.000292	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TERT—melanoma	2.8e-05	0.000291	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RAC1—melanoma	2.79e-05	0.00029	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SYK—melanoma	2.79e-05	0.00029	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	2.78e-05	0.00029	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CD—melanoma	2.77e-05	0.000288	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT3—melanoma	2.74e-05	0.000285	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NGFR—melanoma	2.74e-05	0.000285	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ITGAV—melanoma	2.74e-05	0.000285	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HIF1A—melanoma	2.68e-05	0.000279	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—UGT2B10—melanoma	2.61e-05	0.000271	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP17A1—melanoma	2.6e-05	0.000271	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.58e-05	0.000268	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.57e-05	0.000267	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KDR—melanoma	2.56e-05	0.000266	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—melanoma	2.54e-05	0.000264	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SOCS1—melanoma	2.54e-05	0.000264	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—MAP2K1—melanoma	2.53e-05	0.000263	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—S100B—melanoma	2.53e-05	0.000263	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CD—melanoma	2.51e-05	0.000261	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FN1—melanoma	2.47e-05	0.000256	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GNA11—melanoma	2.46e-05	0.000256	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HS3ST5—melanoma	2.43e-05	0.000252	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ERBB4—melanoma	2.42e-05	0.000252	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOTCH1—melanoma	2.41e-05	0.000251	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CB—melanoma	2.41e-05	0.000251	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—FASN—melanoma	2.41e-05	0.00025	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN2B—melanoma	2.4e-05	0.000249	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—SLC5A5—melanoma	2.37e-05	0.000246	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CD80—melanoma	2.36e-05	0.000246	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APC—melanoma	2.36e-05	0.000245	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CG—melanoma	2.36e-05	0.000245	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KIT—melanoma	2.36e-05	0.000245	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—NRAS—melanoma	2.36e-05	0.000245	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGF—melanoma	2.33e-05	0.000243	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CD86—melanoma	2.32e-05	0.000241	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL8—melanoma	2.32e-05	0.000241	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EDN1—melanoma	2.3e-05	0.000239	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GNAQ—melanoma	2.29e-05	0.000238	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CD44—melanoma	2.29e-05	0.000238	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—MAPK3—melanoma	2.26e-05	0.000235	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CSF2—melanoma	2.25e-05	0.000234	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGF1—melanoma	2.25e-05	0.000234	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.24e-05	0.000233	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.22e-05	0.000231	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—BRAF—melanoma	2.22e-05	0.000231	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2—melanoma	2.22e-05	0.00023	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—E2F1—melanoma	2.2e-05	0.000229	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP1B1—melanoma	2.19e-05	0.000228	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CB—melanoma	2.19e-05	0.000228	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PDGFRA—melanoma	2.18e-05	0.000226	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IGF1—melanoma	2.16e-05	0.000225	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PRKCA—melanoma	2.16e-05	0.000224	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ITGB3—melanoma	2.16e-05	0.000224	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—MAPK1—melanoma	2.15e-05	0.000224	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—EGFR—melanoma	2.15e-05	0.000224	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SPP1—melanoma	2.11e-05	0.00022	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAP2K2—melanoma	2.11e-05	0.000219	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL8—melanoma	2.11e-05	0.000219	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAP2K1—melanoma	2.09e-05	0.000217	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CD—melanoma	2.07e-05	0.000216	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PIK3CA—melanoma	2.05e-05	0.000214	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—KRAS—melanoma	2.03e-05	0.000211	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—melanoma	2.01e-05	0.000209	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TERT—melanoma	2e-05	0.000208	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RAC1—melanoma	2e-05	0.000208	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FGF2—melanoma	1.99e-05	0.000207	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.95e-05	0.000203	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.93e-05	0.000201	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HIF1A—melanoma	1.92e-05	0.000199	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ACER3—melanoma	1.88e-05	0.000196	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CA—melanoma	1.87e-05	0.000194	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MDM2—melanoma	1.86e-05	0.000193	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLCB4—melanoma	1.84e-05	0.000191	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KDR—melanoma	1.83e-05	0.000191	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ERBB2—melanoma	1.83e-05	0.000191	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CB—melanoma	1.81e-05	0.000188	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCB1—melanoma	1.81e-05	0.000188	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	1.8e-05	0.000188	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FN1—melanoma	1.76e-05	0.000184	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL8—melanoma	1.74e-05	0.000181	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC6A11—melanoma	1.73e-05	0.00018	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIP4K2A—melanoma	1.73e-05	0.00018	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOTCH1—melanoma	1.73e-05	0.00018	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—HRAS—melanoma	1.73e-05	0.00018	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—UGT2B10—melanoma	1.72e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN1B—melanoma	1.7e-05	0.000176	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CD80—melanoma	1.69e-05	0.000176	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CG—melanoma	1.69e-05	0.000176	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APC—melanoma	1.69e-05	0.000176	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KIT—melanoma	1.69e-05	0.000176	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—NRAS—melanoma	1.69e-05	0.000176	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTAP—melanoma	1.68e-05	0.000175	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AKT1—melanoma	1.68e-05	0.000175	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGF—melanoma	1.67e-05	0.000174	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CASP3—melanoma	1.66e-05	0.000173	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PRKCA—melanoma	1.66e-05	0.000173	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—melanoma	1.66e-05	0.000173	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—melanoma	1.65e-05	0.000172	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ERCC2—melanoma	1.65e-05	0.000171	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.64e-05	0.000171	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCND1—melanoma	1.62e-05	0.000168	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—MAPK3—melanoma	1.62e-05	0.000168	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CTNNB1—melanoma	1.6e-05	0.000167	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HS3ST5—melanoma	1.6e-05	0.000166	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—BRAF—melanoma	1.59e-05	0.000165	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—melanoma	1.57e-05	0.000163	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN1A—melanoma	1.57e-05	0.000163	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PTEN—melanoma	1.56e-05	0.000162	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NFKB1—melanoma	1.55e-05	0.000162	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF1—melanoma	1.55e-05	0.000161	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—MAPK1—melanoma	1.54e-05	0.00016	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EGFR—melanoma	1.54e-05	0.00016	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AKT1—melanoma	1.52e-05	0.000159	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PHGDH—melanoma	1.5e-05	0.000156	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LUM—melanoma	1.5e-05	0.000156	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAP2K1—melanoma	1.49e-05	0.000155	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CD—melanoma	1.48e-05	0.000154	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CA—melanoma	1.47e-05	0.000153	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HPSE—melanoma	1.47e-05	0.000153	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—KRAS—melanoma	1.45e-05	0.000151	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CUBN—melanoma	1.44e-05	0.00015	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGF2—melanoma	1.42e-05	0.000148	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—melanoma	1.41e-05	0.000147	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT3—melanoma	1.4e-05	0.000145	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NRAS—melanoma	1.39e-05	0.000145	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SDHD—melanoma	1.39e-05	0.000145	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—BSG—melanoma	1.39e-05	0.000145	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CSPG4—melanoma	1.39e-05	0.000145	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.37e-05	0.000142	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GPAM—melanoma	1.35e-05	0.00014	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CA—melanoma	1.34e-05	0.000139	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK3—melanoma	1.33e-05	0.000139	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MDM2—melanoma	1.33e-05	0.000138	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ERBB2—melanoma	1.31e-05	0.000136	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CG—melanoma	1.3e-05	0.000135	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MYC—melanoma	1.3e-05	0.000135	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CB—melanoma	1.29e-05	0.000135	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK1—melanoma	1.27e-05	0.000132	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGFR—melanoma	1.27e-05	0.000132	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—melanoma	1.26e-05	0.000131	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—melanoma	1.24e-05	0.000129	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HRAS—melanoma	1.24e-05	0.000128	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN1B—melanoma	1.21e-05	0.000126	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLCB4—melanoma	1.21e-05	0.000126	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AKT1—melanoma	1.2e-05	0.000125	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KRAS—melanoma	1.2e-05	0.000125	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CASP3—melanoma	1.19e-05	0.000124	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—melanoma	1.19e-05	0.000124	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—melanoma	1.18e-05	0.000123	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCND1—melanoma	1.16e-05	0.00012	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLA2G6—melanoma	1.15e-05	0.000119	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CTNNB1—melanoma	1.15e-05	0.000119	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CD—melanoma	1.14e-05	0.000119	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC6A11—melanoma	1.14e-05	0.000119	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIP4K2A—melanoma	1.14e-05	0.000119	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—melanoma	1.13e-05	0.000117	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—melanoma	1.12e-05	0.000117	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN1A—melanoma	1.12e-05	0.000117	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PTEN—melanoma	1.12e-05	0.000116	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NFKB1—melanoma	1.11e-05	0.000116	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTAP—melanoma	1.11e-05	0.000115	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CA—melanoma	1.1e-05	0.000115	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AKT1—melanoma	1.09e-05	0.000113	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TP53—melanoma	1.07e-05	0.000111	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—VCAN—melanoma	1.03e-05	0.000107	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HRAS—melanoma	1.02e-05	0.000106	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—melanoma	1.01e-05	0.000105	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT3—melanoma	1e-05	0.000104	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NRAS—melanoma	9.98e-06	0.000104	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CB—melanoma	9.97e-06	0.000104	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PHGDH—melanoma	9.89e-06	0.000103	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LUM—melanoma	9.89e-06	0.000103	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—melanoma	9.88e-06	0.000103	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—melanoma	9.76e-06	0.000101	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.76e-06	0.000101	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HPSE—melanoma	9.69e-06	0.000101	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK3—melanoma	9.55e-06	9.94e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CUBN—melanoma	9.52e-06	9.9e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.42e-06	9.79e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MYC—melanoma	9.29e-06	9.66e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SDHD—melanoma	9.19e-06	9.56e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CSPG4—melanoma	9.19e-06	9.56e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—BSG—melanoma	9.19e-06	9.56e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK1—melanoma	9.09e-06	9.45e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGFR—melanoma	9.09e-06	9.45e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKT1—melanoma	9e-06	9.36e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GPAM—melanoma	8.9e-06	9.26e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP17A1—melanoma	8.7e-06	9.04e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTEN—melanoma	8.62e-06	8.96e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KRAS—melanoma	8.59e-06	8.93e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.58e-06	8.92e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	8.47e-06	8.81e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GNA11—melanoma	8.21e-06	8.54e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—FASN—melanoma	8.04e-06	8.36e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC5A5—melanoma	7.91e-06	8.22e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CA—melanoma	7.89e-06	8.2e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GNAQ—melanoma	7.64e-06	7.94e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CD44—melanoma	7.64e-06	7.94e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TP53—melanoma	7.63e-06	7.94e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLA2G6—melanoma	7.57e-06	7.87e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.48e-06	7.77e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.41e-06	7.7e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP1B1—melanoma	7.32e-06	7.61e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HRAS—melanoma	7.3e-06	7.59e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—melanoma	6.99e-06	7.26e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—VCAN—melanoma	6.8e-06	7.07e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.46e-06	6.72e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT1—melanoma	6.44e-06	6.7e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CA—melanoma	6.08e-06	6.32e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCB1—melanoma	6.03e-06	6.27e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP17A1—melanoma	5.74e-06	5.96e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PRKCA—melanoma	5.55e-06	5.77e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ERCC2—melanoma	5.5e-06	5.72e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GNA11—melanoma	5.42e-06	5.63e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—FASN—melanoma	5.3e-06	5.51e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC5A5—melanoma	5.21e-06	5.42e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GNAQ—melanoma	5.04e-06	5.24e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CD44—melanoma	5.04e-06	5.24e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKT1—melanoma	4.97e-06	5.16e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP1B1—melanoma	4.83e-06	5.02e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.56e-06	4.74e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CG—melanoma	4.35e-06	4.52e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—melanoma	4.19e-06	4.36e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCB1—melanoma	3.98e-06	4.13e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CD—melanoma	3.82e-06	3.97e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—melanoma	3.77e-06	3.92e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PRKCA—melanoma	3.66e-06	3.8e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ERCC2—melanoma	3.63e-06	3.77e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CB—melanoma	3.33e-06	3.46e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—melanoma	3.3e-06	3.43e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTEN—melanoma	2.88e-06	2.99e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CG—melanoma	2.87e-06	2.98e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—melanoma	2.77e-06	2.88e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CD—melanoma	2.52e-06	2.62e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—melanoma	2.49e-06	2.59e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CB—melanoma	2.2e-06	2.28e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—melanoma	2.18e-06	2.26e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CA—melanoma	2.03e-06	2.11e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTEN—melanoma	1.9e-06	1.97e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKT1—melanoma	1.66e-06	1.72e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CA—melanoma	1.34e-06	1.39e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKT1—melanoma	1.09e-06	1.14e-05	CbGpPWpGaD
